Table 2.
Symptoms and signs | Frequency* n (%) |
Fever | 95(70.4) |
Weight loss | 88(65.2) |
Cough | 57(42.2) |
Expectoration | 38(28.1) |
Dyspnoea | 34(25.2) |
Diarrhoea | 32(23.7) |
Abdominal pain | 31(23) |
Vomiting | 22(16.3) |
Night sweats | 19(14.1) |
Chest pain | 17(12.6) |
Haemoptysis | 4(3) |
Altered sensorium | 5(3.7) |
Seizures | 4(3) |
Body mass index <19 kg/m2 (n = 78) | 52(66.7) |
Midarm circumference†, in cm (mean ± SD) (n = 76) | 18.9 ± 4.2 |
Triceps skin-fold thickness†, in mm (mean ± SD) (n = 78) | 6.9 ± 1.7 |
Lymphadenopathy – cervical | 39(28.9) |
– axillary | 32(23.7) |
– mediastinal | 18(13.3) |
– retroperitoneal | 15(11.1) |
– generalised | 22(16.3) |
Hepatomegaly | 29(21.5) |
Splenomegaly | 24(17.8) |
Pleural effusion | 15(11.1) |
Ascites | 3(2.2) |
Pericardial effusion | 3(2.2) |
Jaundice | 9(6.7) |
MMSE score <23 | 28(20.7) |
Nuchal rigidity | 12(8.9) |
Focal neurologic deficit | 8(5.9) |
* The denominator is 135, except for anthropometric parameters, where the number of patients is given in parentheses; † Measured at midpoint between acromian and olecranon processes of non-dominant arm: mean of three consecutive readings was taken; MMSE – Mini mental status examination.